Pentoxifylline reduces the first-dose reactions following OKT3

Transplant Proc. 1993 Apr;25(2 Suppl 1):57-9.

Authors

F G Vincenti¹, M Vasconcelos, J L Birnbaum, S J Tomlanovich, W J Amend Jr, J S Melzer, J P Snyder

Affiliation

¹ Kidney Transplant Service, University of California, San Francisco 94143.

PMID: 8465428

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Acetaminophen / therapeutic use
Antigens, CD / analysis
Biopsy
CD3 Complex / analysis
Diphenhydramine / therapeutic use
Graft Rejection / pathology
Graft Rejection / therapy*
Humans
Kidney Transplantation / immunology*
Kidney Transplantation / pathology
Muromonab-CD3 / adverse effects*
Muromonab-CD3 / therapeutic use
Pentoxifylline / therapeutic use*
Prednisolone / therapeutic use
T-Lymphocyte Subsets / immunology
Tumor Necrosis Factor-alpha / analysis

Substances

Antigens, CD
CD3 Complex
Muromonab-CD3
Tumor Necrosis Factor-alpha
Acetaminophen
Diphenhydramine
Prednisolone
Pentoxifylline